Logo

MWG Biotech Seeks to Raise 10M Euros with Convertible Bonds

Nov 19, 2004

NEW YORK, Nov. 19 (GenomeWeb News) - MWG Biotech will issue convertible bonds to raise some €10 million, the Ebersberg, Germany-based company said today.

 

The bonds will pay 6 percent interest per year until Dec. 14, 2007. The bonds are convertible on a 1:1 ratio with MWG Biotech shares.

 

Existing shareholders will be offered the opportunity to purchase one bond for each 3.4 existing shares.

 

The bonds will not be publicly offered and those not underwritten by existing shareholders will be placed with institutional investors, the company said.

Breaking News
The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.